Flaws in the barcoded technology used to reduce medication administration errors ... ( PHILADELPHIA In the first study of ...)

Flaws in the barcoded technology used to reduce medication administration errors identified

Date:7/1/2008

PHILADELPHIA In the first study of its kind, researchers led by The University of Pennsylvania School of Medicine's Ross Koppel, Ph.D. studied how hospital nurses actually use bar-coded technology that matches the right patient with the right dose of the right medication. The surprising result is that the design and implementation of the technology, which is often relied upon as a "cure-all" for medication administration errors, is flawed, and can increase the probabilities of certain errors.

Equally surprising is that the urgencies of care and the ingenuity of nurses to cope with these shortcomings have the unintended consequences of creating other medication errors. These findings appear in the July/August issue of the Journal of the American Medical Informatics Association (JAMIA). The study also illustrates how adjustments to workflow and the technology can dramatically reduce the risk of these errors.

These barcode systems usually consist of handheld devices and computers that match machine-readable barcodes on patients and medications. If they match, and if they are consistent with the ordered medications, the medications are given. If not, usually a signal goes off telling the nurse of a discrepancy.

The study was conducted at 5 hospitals in the Midwest and on the East Coast, but not at the Hospital of the University of Pennsylvania (HUP) because it does not yet have medication barcoding. Penn's Ross Koppel, Ph.D. and his colleagues from other healthcare systems examined close to a half-million instances where nurses and other staff scanned patients and medications. The researchers found a remarkably high proportion of scans involved nurses overriding the technology with workarounds to compensate for difficulties with the barcode systems. These researchers found that nurses scanning the barcode on the medication or the patient's ID bracelet overrode the technology for 4.2% of patients charted and for 10.3% of
'/>"/>

Contact: Marc Kaplan
marc.kaplan@uphs.upenn.edu
215-662-2560
University of Pennsylvania School of Medicine
Source:Eurekalert

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. 39 Noted Performing Artists Urge Congress to Fix Flaws in Presidents Global AIDS Plan
2. Study Indicates Strong Consumer Preference to Fix Medicare Part D and Medicaid Flaws Threatening Access to Prescription Drugs
3. Consumer Group Finds Use of Outdated Data and Other Major Flaws in Economists Defense of Mandatory Purchase of Private Health Insurance
4. Review of group-based cancer trials reveals flaws in studies design and analysis
5. Quantum light beams good for fast technology
6. New Smart Technology Makes Patient Data Collection Easier, More Efficient
7. Align Technology Executive to Present at Upcoming Financial Conferences
8. Pioneer Surgical Technology Hires Vice President of New Business Development
9. Purdue researchers develop technology to detect cancer by scanning surface veins
10. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
11. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology

Post Your Comments:

(Date:12/17/2009)... Good Samaritan Hospital is changing the way ... the launch of the Good Samaritan Hospital Women,s Center ... designed to help treat two common medical problems - ... the bladder, uterus or rectum (pelvic organ prolapse). Three ... leakage and one out of three may experience pelvic ...

(Date:12/17/2009)... National Council on Disability (NCD) will conduct its ... Westheimer, Houston, TX, beginning at 8:30 a.m. on Tuesday, ... Thursday, January 21, 2010. This meeting is open to ... to hear from communities around the country on what ... This meeting will provide another opportunity for that exchange. ...

(Date:12/17/2009)... Data from a recent Thomson Reuters study show that ... papers in 1998 to nearly 112,000 in 2008. ... 2% of the biomedical literature, has evaluated more than ... While only 27 Chinese-authored papers were selected in 2004, ... set to be even higher in 2009. , Jane ...

(Date:12/17/2009)... MA Brandeis University selected Jay and Maureen Neitz, the ... use of gene therapy to treat vision disorders, as ... in Vision Sciences. , The award is funded by ... gift from Brandeis graduates Jay Pepose ,75 and Susan ... graduate research fellowships in vision science. , The Neitzes, ...

(Date:12/17/2009)... The SMARTROLLER®, from OPTP is a uniquely designed, extremely resilient, ... that is flatter and one side that is rounder, making ... , ... Minneapolis, MN (PRWEB) December 17, ... uniquely designed, extremely resilient, ‘two-in-one’ foam roller. This patented foam ...

Breaking Medicine News(10 mins):Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 2 Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 3 Health News:National Council on Disability to Hold Houston Meeting to Hear Issues Affecting People With Disabilities 2 Health News:China rapidly catching up in research impact 2 Health News:Vision researchers Jay and Maureen Neitz to receive first Pepose Award from Brandeis 2 Health News:OPTP Introduces the SMARTROLLER 2

[0] Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health [0] National Council on Disability to Hold Houston Meeting to Hear Issues Affecting People With Disabilities [0] China rapidly catching up in research impact [0] Vision researchers Jay and Maureen Neitz to receive first Pepose Award from Brandeis [0] OPTP Introduces the SMARTROLLER

... vitally important in the fight against HIV and they ... work, according to a new commentary published today in ... Imperial College London, who are evaluating multiple candidate vaccines ... funding agencies must commit to sharing technology and expertise ...

... still do not know what causes epileptic seizures, but ... closer to solving this puzzle with the help of ... is the first human genetic mutation based mouse model ... The mouse is now helping Dr Steven Petrou and ...

... California seniors finds too few health tests , MONDAY, ... received by vulnerable elderly Medicare, Medicaid patients is barely ... at the University of California, Los Angeles, used quality ... Vulnerable Elders project to look at 43 specific types ...

... Quarter of 2007; Company Prepares for ... Integration of Organon BioSciences, KENILWORTH, ... reported financial results for the third,quarter of 2007 and commented ... the Organon human health business,and Intervet animal health business. ...

... settlement agreement with Teva, TOKYO, BRISTOL, ... Inc. ("Astellas"; headquarters: Tokyo; President and CEO: ... and Teva,Pharmaceutical Industries Ltd. ("Teva" Nasdaq: TEVA) ... with Item Development AB ("Item") and,King have ...

... study finds that survival for elderly patients with lung ... expenditures for lung cancer treatment. The study by Harvard ... Research researchers, published in the December 1, 2007 issue ... Society, finds that average life-expectancy rose by less than ...

Fight against HIV needs local scientists, say researchers Childhood epilepsy research offers new hope for seizure control Most Elderly Don't Get Good Medical Care: Study Schering-Plough Reports Financial Results for Third Quarter of 2007 Adenoscan(R) Patent Lawsuits Settled Spending more for lung cancer treatment did not substantially increase patients' lives

(Date:12/17/2009)... Dec. 17 SpectraScience, Inc., (OTC Bulletin Board: ... Hitchin has issued the following letter to shareholders: ,, ... pleased to announce that through the recent closing of ... undertaking several initiatives critical to ramping our business performance ... additions to our European sales force. We are increasing ...

(Date:12/17/2009)... LOUIS, Dec. 17 Express Scripts, ... the largest pharmacy benefit management companies in ... study that examined the association of seizure ... A-rated anti-epileptic drug formulations. The study found ... drugs, including brand to generic substitution, was ...

(Date:12/17/2009)... RALEIGH, N.C., Dec. 17 Pharmaceutical Institute ... from GeneEd, Inc., a company specializing in life ... advanced e-courses, help expand Pharmaceutical Institute,s already extensive ... Institute is a leading provider of specialized training ... a subsidiary of Campbell Alliance. Financial terms ...

Breaking Medicine Technology:SpectraScience Releases Shareholder Newsletter 2 SpectraScience Releases Shareholder Newsletter 3 SpectraScience Releases Shareholder Newsletter 4 SpectraScience Releases Shareholder Newsletter 5 Express Scripts Study Finds No Association Between Anti-Epileptic Drug Switches and Increased Seizure Activity 2 Express Scripts Study Finds No Association Between Anti-Epileptic Drug Switches and Increased Seizure Activity 3 Pharmaceutical Institute Acquires E-Learning Assets from GeneEd, Inc. 2 Pharmaceutical Institute Acquires E-Learning Assets from GeneEd, Inc. 3 U S News Media Group Announces 2009 10 Americas Best Hospitals 51886 1 U S News Media Group Announces 2009 10 Americas Best Hospitals 51886 2 U S News Media Group Announces 2009 10 Americas Best Hospitals 51886 3 U S News Media Group Announces 2009 10 Americas Best Hospitals 51886 4 Mylan Receives FDA Approval for Generic Version of Thyroid Deficiency Treatment Cytomel 28R 29 51884 1 Cancer Patients Benefit From Speed Accuracy of RapidArc Radiotherapy Treatments 51882 1 Cancer Patients Benefit From Speed Accuracy of RapidArc Radiotherapy Treatments 51882 2 Cancer Patients Benefit From Speed Accuracy of RapidArc Radiotherapy Treatments 51882 3

[0] SpectraScience Releases Shareholder Newsletter [0] Express Scripts Study Finds No Association Between Anti-Epileptic Drug Switches and Increased Seizure Activity [0] Pharmaceutical Institute Acquires E-Learning Assets from GeneEd, Inc.

... and RESEARCH TRIANGLE PARK, N.C., Nov. 2 /PRNewswire/,-- ... GSK ),announced today that the U.S. Food and ... for the new drug application for gepirone extended-,release ... with major,depressive disorder. The FDA had previously ...

... Inc.,(Nasdaq: IDMI ) today announced updated results ... trial (DC-MEL-202). The updated results,showed that the investigational ... of immune response and was well tolerated in,patients ... presented during a poster session at the,International Society ...

Other Medicine Technology:Fabre Kramer Pharmaceuticals Receives Decision From FDA on Gepirone ER for Major Depressive Disorder 2 IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients 2 IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients 3 IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients 4

Fabre Kramer Pharmaceuticals Receives Decision From FDA on Gepirone ER for Major Depressive Disorder IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients

... a qualitative enzyme immunoassay (EIA) that ... capsid antigen (EBV-VCA), Epstein-Barr early nuclear ... When used in conjunction with Mono-M ... the serodiagnosis of infectious (EBV) mononucleosis ...

... an ELISA method for the qualitative detection of ... (VCA) in human serum. When the VCA IgG ... such as the EBV nuclear antigen (EBNA-1), VCA ... tests, the results can serve as an aid ...

... (Lyme) test is an enzyme ... the qualitative detection of borrelia ... related Borrelia burgdorferi antibodies (IgG, ... in serum as an aid ...

The ImmunoWELL Borrelia (Lyme) Test is an enzyme immunoassay (EIA) for the qualitative and/or semiquantitative detection of Borrelia burgdorferi total antibodies (IgG, IgM, and IgA) in serum and is u...

Medicine Products:

ImmunoDOT Mono G Test ImmunoWELL EBV VCA IgG Test ImmunoDOT Borrelia (Lyme) Test (with Recombinant Protein)ImmunoWELL Borrelia (Lyme) Test

Flaws in the barcoded technology used to reduce medication administration errors ...( PHILADELPHIA In the first study of ...),Health